Literature DB >> 3977523

IgA nephropathy associated with disseminated tuberculosis.

A J Cohen, E D Rosenstein.   

Abstract

A 59-year-old man had disseminated tuberculosis and microscopic hematuria, red cell casts, and normal renal function. Renal biopsy revealed focal mesangial proliferation with exclusively IgA deposits, diagnostic of IgA nephropathy. After institution of antituberculous therapy, the urinary abnormalities resolved. There is evidence to suggest that tuberculosis, in addition to other conditions associated with mucosal exposure to antigens producing an IgA immune response, can result in IgA nephropathy. This glomerulopathy is reported as a potential renal complication of concurrent mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977523

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Crescentic Glomerulonephritis Associated with Pulmonary Tuberculosis.

Authors:  K V Kanodia; A V Vanikar; R D Patel; K S Suthar; H L Trivedi
Journal:  J Clin Diagn Res       Date:  2016-01-01

2.  Lupus vulgaris with tubercular lymphadenitis and IgA nephropathy.

Authors:  Ambar Khaira; Om P Rathi; Sandeep Mahajan; Alok Sharma; Amit K Dinda; Suresh C Tiwari
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

3.  Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis.

Authors:  Roberto Bueno Filho; Alberto Pinto Cordeiro; Flavia Tremeschin de Almeida; Catarina Shaletich; Roberto Silva Costa; Ana Maria F Roselino
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

4.  Pulmonary hemorrhage with hematuria: do not forget IgA nephropathy.

Authors:  Kemi Oluwole; Linda Esuzor; Oluwafisayo Adebiyi; Chike Nzerue; Marquetta Faulkner; Ebele Umeukeje; Paisit Paueksakon
Journal:  Clin Kidney J       Date:  2012-10

Review 5.  Tuberculosis-associated IgA nephropathy.

Authors:  Yamei Wang; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.